{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:08:58Z","timestamp":1762024138789,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["ASPIRE 2018 , ATTR Grant Program for Junior Investigators"],"award-info":[{"award-number":["ASPIRE 2018 , ATTR Grant Program for Junior Investigators"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yexcr.2020.112217","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T02:00:59Z","timestamp":1596592859000},"page":"112217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["SERPINA1 modulates expression of amyloidogenic transthyretin"],"prefix":"10.1016","volume":"395","author":[{"given":"Christoph","family":"Niemietz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ros\u00e1rio","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett P.","family":"Monia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jo\u00e3o","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut H.-J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andree","family":"Zibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2020.112217_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2020.112217_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.yexcr.2020.112217_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/excr.1996.0010","article-title":"Retinol binding protein and transthyretin are secreted as a complex formed in the endoplasmic reticulum in HepG2 human hepatocarcinoma cells","volume":"222","author":"Bellovino","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2020.112217_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2020.112217_bib5","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.1713689115","article-title":"Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema","volume":"115","author":"Borel","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.112217_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neuroscience.2014.06.019","article-title":"Silencing of murine transthyretin and retinol binding protein genes has distinct and shared behavioral and neuropathologic effects","volume":"275","author":"Buxbaum","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.yexcr.2020.112217_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.chembiol.2014.09.009","article-title":"ATF6 activation reduces the secretion and extracellular aggregation of destabilized variants of an amyloidogenic protein","volume":"21","author":"Chen","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.yexcr.2020.112217_bib8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V90.4.1501","article-title":"Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2)","volume":"90","author":"Citarella","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2020.112217_bib9","series-title":"SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency J Nucleic Acids 2018","first-page":"8247935","author":"Connolly","year":"2018"},{"key":"10.1016\/j.yexcr.2020.112217_bib10","first-page":"1415","article-title":"Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes","volume":"9","author":"Costa","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112217_bib11","first-page":"4697","article-title":"Transcriptional control of the mouse prealbumin (transthyretin) gene: both promoter sequences and a distinct enhancer are cell specific","volume":"6","author":"Costa","year":"1986","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112217_bib12","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nbt.3678","article-title":"Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions","volume":"34","author":"Ernst","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.112217_bib13","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1523\/JNEUROSCI.6012-08.2009","article-title":"Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity","volume":"29","author":"Fleming","year":"2009","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.yexcr.2020.112217_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2020.112217_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-008-9841-2","article-title":"Transthyretin is up-regulated by sex hormones in mice liver","volume":"317","author":"Goncalves","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2020.112217_bib16","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1021\/bi7016377","article-title":"Transthyretin interacts with metallothionein 2","volume":"47","author":"Goncalves","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.yexcr.2020.112217_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neurobiolaging.2016.07.020","article-title":"Tissue remodeling after interference RNA mediated knockdown of transthyretin in a familial amyloidotic polyneuropathy mouse model","volume":"47","author":"Goncalves","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.yexcr.2020.112217_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12974-017-0891-9","article-title":"Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system","volume":"14","author":"Goncalves","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.yexcr.2020.112217_bib19","article-title":"Using antisense technology to develop a novel therapy for alpha-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease","volume":"2","author":"Guo","year":"2014","journal-title":"Rare Dis."},{"key":"10.1016\/j.yexcr.2020.112217_bib20","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.112217_bib21","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1038\/s41598-018-26762-1","article-title":"Radiation-induced overexpression of transthyretin inhibits retinol-mediated hippocampal neurogenesis","volume":"8","author":"Kang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2020.112217_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177279","article-title":"Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression","volume":"12","author":"Karadagi","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2020.112217_bib23","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1074\/jbc.M113.542399","article-title":"Deficiency of oncostatin M receptor beta (OSMRbeta) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice","volume":"289","author":"Komori","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.112217_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jhep.2018.04.018","article-title":"Liver - master and servant of serum proteome","volume":"69","author":"Kuscuoglu","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2020.112217_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/MCB.21.2.414-424.2001","article-title":"Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury","volume":"21","author":"Leu","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112217_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nm.3485","article-title":"FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS","volume":"20","author":"Liu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2020.112217_bib27","doi-asserted-by":"crossref","first-page":"21431","DOI":"10.1074\/jbc.M402212200","article-title":"Transthyretin, a new cryptic protease","volume":"279","author":"Liz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.112217_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/BJ20082090","article-title":"Substrate specificity of transthyretin: identification of natural substrates in the nervous system","volume":"419","author":"Liz","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2020.112217_bib29","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/j.1742-4658.2010.07749.x","article-title":"Human metallothioneins 2 and 3 differentially affect amyloid-beta binding by transthyretin","volume":"277","author":"Martinho","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.yexcr.2020.112217_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.gene.2013.06.078","article-title":"A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERalpha and\/or ERbeta transactivation","volume":"527","author":"Martinho","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2020.112217_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12967-015-0585-y","article-title":"Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency","volume":"13","author":"Matamala","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2020.112217_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/bj20011312","article-title":"Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer","volume":"365","author":"Morgan","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2020.112217_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/CCLM.2007.051","article-title":"Committee on Plasma Proteins, M. Laboratory, Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition","volume":"45","author":"Myron Johnson","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yexcr.2020.112217_bib34","doi-asserted-by":"crossref","first-page":"17944","DOI":"10.3390\/molecules201017944","article-title":"Therapeutic oligonucleotides targeting liver disease: TTR amyloidosis","volume":"20","author":"Niemietz","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.yexcr.2020.112217_bib35","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.219824","article-title":"Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis","volume":"131","author":"Niemietz","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2020.112217_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1096\/fj.05-4106fje","article-title":"Transthyretin knockouts are a new mouse model for increased neuropeptide Y","volume":"20","author":"Nunes","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.yexcr.2020.112217_bib37","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.1016\/S0021-9258(18)60557-5","article-title":"The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line","volume":"264","author":"Perlmutter","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.112217_bib38","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/MCB.15.3.1364","article-title":"Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription","volume":"15","author":"Qian","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112217_bib39","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","article-title":"The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex","volume":"244","author":"Raz","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.112217_bib40","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.91.18.8368","article-title":"Transthyretin sequesters amyloid beta protein and prevents amyloid formation","volume":"91","author":"Schwarzman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2020.112217_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0016-5085(76)80506-9","article-title":"The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease","volume":"70","author":"Sharp","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2020.112217_bib42","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1074\/jbc.M809354200","article-title":"The endoplasmic reticulum-associated degradation of transthyretin variants is negatively regulated by BiP in mammalian cells","volume":"284","author":"Susuki","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.112217_bib43","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2003-02-0367","article-title":"Targeted disruption of oncostatin M receptor results in altered hematopoiesis","volume":"102","author":"Tanaka","year":"2003","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/j.yexcr.2020.112217_bib44","article-title":"Oncostatin M in the anti-inflammatory response","volume":"60","author":"Wahl","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2020.112217_bib45","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1074\/jbc.M116.748483","article-title":"Murine oncostatin M acts via leukemia inhibitory factor receptor to phosphorylate signal transducer and activator of transcription 3 (STAT3) but not STAT1, an effect that protects bone mass","volume":"291","author":"Walker","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2020.112217_bib46","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.4049\/jimmunol.162.9.5547","article-title":"Regulation of inflammatory responses by oncostatin M","volume":"162","author":"Wallace","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2020.112217_bib47","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1523\/JNEUROSCI.4936-13.2014","article-title":"The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice","volume":"34","author":"Wang","year":"2014","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.yexcr.2020.112217_bib48","first-page":"3273","article-title":"Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo","volume":"31","author":"Weiss","year":"2011","journal-title":"Anticancer Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720304663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720304663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:33:28Z","timestamp":1757997208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482720304663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0014482720304663"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.112217","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SERPINA1 modulates expression of amyloidogenic transthyretin","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.112217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112217"}}